Athira Pharma: Fosgonimeton May Outperform Lecanemab In Alzheimer's
Seeking Alpha,
Follow Summary Athira Pharma’s stock has sold off some months ago on its Alzheimer’s drug candidate Fosgonimeton not meeting a…
Faked Beta-Amyloid Data. What Does It Mean?
Science Magazine,
Late last week came this report in Science about doctored images in a series of very influential papers on amyloid and Alzheimer…
PureTech turns 200-year-old discovery into a new approach to Alzheimer's, while clinging to controversial amyloid ...
End Points,
Jason Mast Editor Before MRIs or CT scans, 18th-century anatomist Paolo Mascagni injected his cadavers with mercury.
Anti-Amyloid Drugs: The Advantages Of Alzheon's ALZ-801 Over Biogen's Aducanumab
Seeking Alpha,
Summary Alzheon received funding from the National Institutes of Health to conduct a phase 3 clinical trial for its drug ALZ-801…